NDLEA DISMANTLES ABUJA DRUG BUNKS, ARRESTS 132, RECOVERS 220KG ILLICIT SUBSTANCES. (PHOTOS). #PRESS RELEASE.

-
Image
 NDLEA dismantles Abuja drug bunks, arrests 132, recovers 220kg illicit substances  -Marwa hails operation, vows to sustain crackdown in FCT, other states  In a non-stop two-week offensive action against traffickers and dealers, operatives of the National Drug Law Enforcement Agency (NDLEA) have successfully dismantled several drug joints and bunks within and around the Federal Capital Territory (FCT) Abuja where a total of 132 suspects were arrested and 220 kilograms of assorted illicit substances recovered. The wel-coordinated raids jointly conducted by the Agency's Directorate of Operations and General Investigation (DOGI) and the FCT Strategic Command from llth to 25th April 2026 were launched to dismantle illicit drug hubs contributing to substance abuse, trafficking, and associated criminal activities in the capital city after weeks of intelligence and surveillance across all identified hotspots. Areas where notorious drug joints were raided, dismantled and suspects...
Post a Comment

GENE THERAPY OFFERS NEW SICKLE CELL CURE IN THE U. S. (PHOTO).

-


 Gene Therapy Offers New Sickle Cell Cure in the US


Sebastien Beauzile, a 21-year-old from Laurelton, Long Island, has become the first person in New York State to be cured of sickle cell anemia using the groundbreaking Lyfgenia gene therapy.


Administered at Cohen Children’s Medical Center, this innovative treatment provides hope for many suffering from the painful genetic disorder, Forbes reported on Sunday.


A Lifelong Battle

Sickle cell anemia causes abnormally shaped red blood cells, leading to severe pain and potential organ damage. Beauzile, diagnosed at just four months old, endured frequent hospitalizations due to intense pain crises, which he described as “10 out of 10” in severity.


Gene Therapy Breakthrough

Developed by Bluebird Bio and approved by the FDA in December 2023, Lyfgenia works by extracting a patient’s blood stem cells, genetically modifying them to include functional hemoglobin genes, and reinfusing them into the bloodstream. This cutting-edge approach marks a major step forward in treating sickle cell disease.

Comments

Post a Comment